Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with 99m Tc-peptide-Z HER2:342
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine
Reference35 articles.
1. Resistance to trastuzumab in breast cancer;Pohlmann;Clin Cancer Res,2009
2. HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance;Verri;Oncology,2005
3. Cancer statistics;Jemal;CA Cancer J Clin,2008
4. Screening and detection of ovarian cancer;Breedlove;J Midwifery Womens Health,2005
5. Trastuzumab and gemcitabine in pretreated HER2 overexpressing metastatic breast cancer patients: retrospective analysis of our series;Di Lauro;J Oncol,2012
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ImmunoPET: Antibody-Based PET Imaging in Solid Tumors;Frontiers in Medicine;2022-06-28
2. The Potential Usefulness of 99mTc-HYNIC-(Ser)3-LTVPWY Peptide for Predicting HER2 Status Alteration After Chemotherapy in Ovarian Tumor-Bearing Mice;Cancer Biotherapy and Radiopharmaceuticals;2020-09-07
3. PET imaging of a 68Ga labeled modified HER2 affibody in breast cancers: from xenografts to patients;The British Journal of Radiology;2019-12
4. Therapeutic efficacy and imaging assessment of the HER2-targeting chemotherapy drug ZHER2:V2-pemetrexed in lung adenocarcinoma Xenografts;Investigational New Drugs;2019-11-23
5. PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules;Molecular Imaging and Biology;2019-01-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3